# THE GAIN

> THE GAIN is a VC fund backing Information Technology. See 21 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 21
- Last investment: Jan 2024
- Lead investor: 5%
- Last updated: Aug 2026

THE GAIN is a VC fund focused on Information Technology and Artificial Intelligence.

## Contacts

5 contacts available for THE GAIN. Shizune tracks 1 team members at THE GAIN. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/the-gain?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Information Technology | 8 | 38% |
| Artificial Intelligence | 7 | 33% |
| Software | 5 | 24% |
| Machine Learning | 4 | 19% |
| Health Care | 3 | 14% |

32 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 18 | 86% |
| Seed | 2 | 10% |
| Pre-Seed | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 20 | 95% |
| United States | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| B. V. Naidu | Founder & Chairman | 12 | https://shizune.co/investors/profile/b-v-naidu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hesa | Hesa unifies value chains in rural India by enabling local brands and businesses to come together as a community. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| Doppelio | The Doppelio Perhaps one of the most undervalued functions is testing. Most folks think that decoding software code is a fun profession. So did we, until we were given the task of creating a smart building platform with 5000+ sensors and 250+ business rules in each building. Building management systems and infrastructure are placed in eachstructure. The product was ready for that use. There was one step left to do, as predicted: testing the solution in all scenarios and for each building. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| ExactSpace | ExactSpace is an Industrial AI business dedicated to assisting industries in answering these difficult questions and building a greener future. Access to data is only the first step; ExactSpace completes the cycle by providing contextual and meaningful data insights. ExactSpace combines modern analytic methodologies such as Machine Learning andArtificial Intelligence with deep domain experience to offer extremely vertically specific solutions that have the greatest impact on our customers. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| AyuRythm | AyuRythm is a hyper-personalised digital companion for holistic wellness, with a blend of modern technologies with the ancient science of health assessment and care. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| Piatrika Biosystems | Piatrika Biosystems is an innovative platform that helps researchers and plant breeders bring Sustainable Seeds and Agri Chemicals to market faster and cheaper. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| AarogyaAI | AarogyaAI is an artificial intelligence-based software as a service that diagnoses drug-resistant tuberculosis. AarogyaAI uses a DNA sequence from the patient which is uploaded to SaaS. Its machine-learning algorithm then gives an output report of a comprehensive drug susceptibility status of the patient. |  | Venture - Series Unknown | Jan 01, 2024 |  |
| LivNSense Technologies | LivNSense Technologies provides cross-functional insights and predictive foresight by creating live digital twins of the collected data along with the economic impact assessment of every current or potential anomaly. The cloud-agnostic platform is available with on-premises, hybrid and cloud deployment options. | $2.8M | Seed | Dec 25, 2023 |  |
| Leucine Rich Bio | Leucine Rich Bio is India's first and only Microbiome focused Genomics Based company. While, genomic approaches have gained huge clinical importance allowing us to align towards precision medicine, important uncertainties remain unanswered. The human microbiome, largely recognized as the "Second Genome", while rooted in theprinciples of genomics, have gained tremendous steam over the past few years. There is a heightened interest among researchers, clinicians and direct consumers in understanding the effects of the microbiome on health and wellness. |  | Seed | Oct 17, 2023 |  |
| Hyperhire | They become the mixologist that seamlessly blends the human skills with the emerging technology, to create a beautiful blend of workplace experiences fit for the working world of today and tomorrow. |  | Venture - Series Unknown | Jan 01, 2023 |  |
| ExtraaEdge | ExtraaEdge’s Admission & marketing automation CRM software is specifically designed for educational enterprises. Predict, Manage & Increase their admissions. At ExtraaEdge we use the power of data science & machine learning to help the billion dollar education industry predict their sales i.e. admissions.Think of us as Salesforce +Hubspot for education industry. We operate in the 22.6 billion dollar education marketing software space.We do this via our proprietary Admission & Marketing Automation CRM software built dedicated for the edu industry. This helps edu marketing teams reduce the cost of student acquisition & increase their conversions using our software.Use cases : (0) Predict admissions based on historical data, online, social & funnel intelligence. (1) Increase marketing Return On Investment (ROI ) (2) Increase the efficiency of admission counselling teams via smart follow-ups & calendars (3) Accelerate lead engagement via marketing automation playbooks (4) Track your end to end marketing and admissions activities to take decisions. |  | Venture - Series Unknown | Jan 01, 2023 |  |

10 of 21 investments shown.

## Co-investors
- [Forge Innovation & Ventures](https://shizune.co/investors/profile/forge-accelerator) — VC Fund, 1 deal together
- [Pavestone Capital](https://shizune.co/investors/profile/pavestone-capital) — VC Fund, 1 deal together
- [R/GA Ventures](https://shizune.co/investors/profile/r-ga-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does THE GAIN invest in?

THE GAIN invests primarily in Information Technology, Artificial Intelligence and Software startups, most often at Venture - Series Unknown and Seed stage. Most of the 21 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact THE GAIN?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at THE GAIN?

The team at THE GAIN includes B. V. Naidu (Founder & Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co